Original Article
Expression of Estrogen Receptor and Progesterone Receptor in Malignant Epithelial Ovarian Tumors
*Shams S,1 Das R,2 Saha S3
- * Sifat Shams, Medical Officer, Department of Neuropathology, National Institute of Neurosciences and Hospital, Dhaka, Bangladesh. sifatshams24@gmail.com.
- Reba Das, Assistant Professor, Department of Pathology, Sathkhira Medical College Hospital, Sathkhira, Bangladesh
- Shawni Saha, Assistant Professor, Department of Pathology, Shaheed Suhrawardy Medical College Hospital, Bangladesh
*For correspondence
Abstract
Background: Malignant epithelial ovarian tumors are a significant cause of cancer-related deaths in women. The expression of estrogen and progesterone receptors (ER and PR) in these tumors has been studied extensively, as they play a critical role in the pathogenesis and treatment of ovarian cancer. ER and PR expression levels in ovarian tumors can impact treatment decisions and patient outcomes. Therefore, understanding the frequency and distribution of ER and PR expression in different types of ovarian tumors is crucial in improving patient care.
Method: This cross-sectional observational study was conducted at the Department of Pathology, Sir Salimullah Medical College and Mitford Hospital, Dhaka, Bangladesh. The study duration was 2 years, from January 2018 to December 2019. During this period, a total of 45 adult female patients with histopathologically diagnosed malignant epithelial ovarian tumors by H&E staging were selected for the study.
Results: In this study, the majority of participants were aged 41-60 years and reported irregular menstrual cycles or being post-menopausal. Most were nulliparous, and the mean CA125 level was 149.51. Serous cystadenocarcinoma was the most common diagnosis (68.89%). ER was positive in 51.11% of cases, with a higher proportion in serous cystadenocarcinoma (64.52%) compared to mucinous cystadenocarcinoma. PR was positive in 80% of cases, with the highest proportion in endometrioid carcinoma (50%). ER expression was significantly higher in serous tumors compared to non-serous tumors (p=0.002), but the association between tumor type and PR expression was not significant (p=0.192).
Conclusion: The study found that the majority of participants were aged 41-60 years, had irregular menstrual cycles, or were post-menopausal. Serous cystadenocarcinoma was the most common diagnosis. A significant difference in ER positivity was observed between serous and mucinous cystadenocarcinoma, as well as other subtypes. PR positivity was observed in the majority of participants, but no significant association was observed with histopathological subtypes or serous types.
[Journal of Histopathology and Cytopathology, 2025 Jan; 9 (1):10-19]
DOI: https://www.doi.org/10.69950/jhc2025v9i1s3
Keywords: Estrogen, Progesterone, Cancer, Carcinoma, Ovarian, Malignant